Yongwhi Park, A. Her, Hyun Kuk Kim, J. Moon, J. Park, K. Park, Kyung Hoon Lee, H. Joo, Ho-Yeon Won, S. Ahn, H. Park, Sung‐Jin Hong, B. Kim, S. Ban, J. Suh, Y. Song, J. Cho, Y. Jeong, Weon Kim, E. Shin
{"title":"Consensus Document on Perioperative Antithrombotic Management: Part 2. Case Study","authors":"Yongwhi Park, A. Her, Hyun Kuk Kim, J. Moon, J. Park, K. Park, Kyung Hoon Lee, H. Joo, Ho-Yeon Won, S. Ahn, H. Park, Sung‐Jin Hong, B. Kim, S. Ban, J. Suh, Y. Song, J. Cho, Y. Jeong, Weon Kim, E. Shin","doi":"10.3904/kjm.2022.97.4.204","DOIUrl":null,"url":null,"abstract":"Given the progressive improvements in antithrombotic strategies, management of cardiovascular disease has become sophisticated/refined. However, the optimal perioperative management of antithrombotic therapy in patients with acute coronary syndrome or who are scheduled for percutaneous coronary intervention remains unclear. Assessments of the thrombotic and hemorrhagic risks are essential to reduce the rates of mortality and major cardiac events. However, the existing guidelines do not mention these topics. This case-based consensus document deals with common clinical scenarios and offers evidence-based guidelines for individualized perioperative management of antithrombotic therapy in the real world.","PeriodicalId":84452,"journal":{"name":"Chungang uihak = The Korean central journal of medicine","volume":"19 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chungang uihak = The Korean central journal of medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3904/kjm.2022.97.4.204","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Given the progressive improvements in antithrombotic strategies, management of cardiovascular disease has become sophisticated/refined. However, the optimal perioperative management of antithrombotic therapy in patients with acute coronary syndrome or who are scheduled for percutaneous coronary intervention remains unclear. Assessments of the thrombotic and hemorrhagic risks are essential to reduce the rates of mortality and major cardiac events. However, the existing guidelines do not mention these topics. This case-based consensus document deals with common clinical scenarios and offers evidence-based guidelines for individualized perioperative management of antithrombotic therapy in the real world.